We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILA icon
11451
Liberty Latin America Class A
LILA
$1.69B
$85K ﹤0.01%
+15,962
New +$99.4K
NVNO
11452
CALL
enVVeno Medical
NVNO
$7.5M
$85K ﹤0.01%
646
-428
-40% -$66.4K
RBOT
11453
DELISTED
Vicarious Surgical
RBOT
$85K ﹤0.01%
961
-143
-13% -$17.5K
SRET icon
11454
Global X SuperDividend REIT ETF
SRET
$230M
$85K ﹤0.01%
3,529
-1,501
-30% -$38.5K
SUP
11455
PUT
DELISTED
Superior Industries International
SUP
$85K ﹤0.01%
21,600
-5,300
-20% -$20.8K
HGEN
11456
PUT
DELISTED
HUMANIGEN, INC.
HGEN
$85K ﹤0.01%
48,200
-66,500
-58% -$149K
HEXO
11457
DELISTED
HEXO Corp. Common Shares
HEXO
$85K ﹤0.01%
+28,819
New +$138K
ANY icon
11458
PUT
Sphere 3D
ANY
$18.1M
$84K ﹤0.01%
2,231
-2,313
-51% -$200K
CCCC icon
11459
CALL
C4 Therapeutics
CCCC
$522M
$84K ﹤0.01%
11,200
-9,300
-45% -$81.8K
DOGZ icon
11460
PUT
Dogness International Corp
DOGZ
$16.8M
$84K ﹤0.01%
2,315
+1,035
+81% +$82.7K
EPM icon
11461
PUT
Evolution Petroleum
EPM
$135M
$84K ﹤0.01%
15,400
-10,000
-39% -$67.3K
SLS icon
11462
SELLAS Life Sciences
SLS
$2.58B
$84K ﹤0.01%
37,639
+24,269
+182% +$71.1K
SOL
11463
PUT
DELISTED
Emeren Group
SOL
$84K ﹤0.01%
17,600
-8,700
-33% -$42.4K
SXC icon
11464
CALL
SunCoke Energy
SXC
$794M
$84K ﹤0.01%
+12,300
New +$99.2K
VSTM icon
11465
Verastem
VSTM
$596M
$84K ﹤0.01%
5,980
-6,290
-51% -$100K
OSG
11466
DELISTED
Overseas Shipholding Group Inc.
OSG
$84K ﹤0.01%
40,654
-10,749
-21% -$23K
LEXX icon
11467
Lexaria Bioscience
LEXX
$14.9M
$83K ﹤0.01%
+1,859
New +$74.7K
MUX icon
11468
PUT
McEwen Inc
MUX
$1.15B
$83K ﹤0.01%
18,970
+5,320
+39% +$33.1K
OPRT icon
11469
CALL
Oportun Financial
OPRT
$355M
$83K ﹤0.01%
+10,000
New +$115K
ORGO icon
11470
PUT
Organogenesis Holdings
ORGO
$230M
$83K ﹤0.01%
17,100
-1,700
-9% -$10.5K
PGEN icon
11471
CALL
Precigen
PGEN
$2.18B
$83K ﹤0.01%
62,000
+3,300
+6% +$4.9K
TTI icon
11472
CALL
TETRA Technologies
TTI
$1.27B
$83K ﹤0.01%
20,500
-26,100
-56% -$115K
GOEV
11473
PUT
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$83K ﹤0.01%
98
-94
-49% -$165K
ATEC icon
11474
PUT
Alphatec Holdings
ATEC
$1.51B
$82K ﹤0.01%
12,600
-9,400
-43% -$86.6K
SRXH
11475
SRX Global
SRXH
$37.5M
$82K ﹤0.01%
19
+11
+138% +$51.5K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.